• Earlier in Q2 2026, Colgate-Palmolive reported higher net and organic sales, wider margins, and stronger free cash flow, while worldwide organic volume increased for a third consecutive quarter despite a difficult operating backdrop.
• In July 2026, management kept its full-year outlook for net sales and double-digit GAAP EPS growth intact, suggesting that recent volume gains and margin improvements are feeding into a more confident operational plan.
• We’ll now examine how this continued organic volume growth and maintained guidance influence Colgate-Palmolive’s existing investment narrative.

Find 51 companies with promising cash flow potential yet trading below their fair value.

Colgate-Palmolive Investment Narrative Recap

To own Colgate-Palmolive, I think you need to believe its global brands and everyday essentials can keep driving steady volumes even when consumers are cautious. The recent pickup in organic volume and maintained guidance supports that view and modestly improves the near term growth catalyst, but it does not remove the key risk that category softness in major markets could still cap overall volume and revenue progress.

The reaffirmed 2026 outlook for 2% to 6% net sales growth and double digit GAAP EPS growth is the announcement that ties most directly to this quarter’s results, because it shows management is treating the recent combination of higher volumes, pricing, and wider margins as consistent with its existing plan rather than resetting expectations, which matters for how investors weigh near term execution against ongoing macro and input cost pressures.

Yet even with better volumes, investors should be aware that persistent consumer caution in key markets could still...

Colgate-Palmolive's narrative projects $23.1 billion revenue and $3.4 billion earnings by 2029. This requires 3.2% yearly revenue growth and a $1.4 billion earnings increase from $2.0 billion.

Uncover how Colgate-Palmolive's forecasts yield a $98.95 fair value, a 7% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community span roughly US$86 to US$128 per share, showing how far apart individual views can be. Set against this, the reliance on ongoing organic volume growth in a still cautious consumer backdrop gives you a clear reason to compare several of these perspectives before deciding how Colgate-Palmolive might fit into your portfolio.

Explore 4 other fair value estimates on Colgate-Palmolive - why the stock might be worth 6% less than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Colgate-Palmolive research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Colgate-Palmolive research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Colgate-Palmolive's overall financial health at a glance.

Want Some Alternatives?

Our top stock finds are flying under the radar-for now. Get in early:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.
• Uncover the next big thing with 23 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.